AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P17
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
2025-32.73%
2024-33.63%
202335.28%
202257.02%
20211442.65%
2020-25.72%
20190.00%